Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM)
Noonan syndrome
childhood
disease course
outcome
Journal
Cardiovascular diagnosis and therapy
ISSN: 2223-3652
Titre abrégé: Cardiovasc Diagn Ther
Pays: China
ID NLM: 101601613
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
entrez:
19
11
2019
pubmed:
19
11
2019
medline:
19
11
2019
Statut:
ppublish
Résumé
To compare outcome and cardiac pathology between patients with Noonan syndrome (N-HCM) and sarcomere protein-associated (S-HCM) childhood onset hypertrophic cardiomyopathy (HCM). Clinical data were recorded from medical charts. Primary endpoint was survival. Secondary endpoints were survival without hospitalization, without intervention or without arrhythmic events. Functional clinical status and results from genetic testing, imaging, electrocardiographic (ECG) studies, cardiopulmonary exercise testing (CPET) and histopathology were compared between groups. Childhood HCM was diagnosed in 29 N-HCM and 34 S-HCM patients. Follow-up time was greater than 10 years in more than half of all patients. Mortality was below 7% and not different between groups. Children with N-HCM presented at a younger age and there was less time of survival without hospitalization for heart failure or intervention in N-HCM compared to S-HCM patients. Clinical functional status improved over time in N-HCM patients. On long-term follow-up, left ventricular posterior wall thickness indexed to body surface area decreased in N-HCM and increased in S-HCM patients. There was a trend to lower risk for severe arrhythmic events in N-HCM patients and only S-HCM individuals received an implantable cardioverter-defibrillator. There were no differences between groups in ventricular function, ECG and CPET parameters. Myocardial fibrosis as assessed by histopathology of myocardial specimens and cardiovascular magnetic resonance with late gadolinium enhancement or T1 mapping was present in both groups. When compared to S-HCM patients, children with N-HCM have increased morbidity during early disease course, but favorable long-term outcome with low mortality, stagnation of myocardial hypertrophy, and low risk for malignant arrhythmias.
Sections du résumé
BACKGROUND
BACKGROUND
To compare outcome and cardiac pathology between patients with Noonan syndrome (N-HCM) and sarcomere protein-associated (S-HCM) childhood onset hypertrophic cardiomyopathy (HCM).
METHODS
METHODS
Clinical data were recorded from medical charts. Primary endpoint was survival. Secondary endpoints were survival without hospitalization, without intervention or without arrhythmic events. Functional clinical status and results from genetic testing, imaging, electrocardiographic (ECG) studies, cardiopulmonary exercise testing (CPET) and histopathology were compared between groups.
RESULTS
RESULTS
Childhood HCM was diagnosed in 29 N-HCM and 34 S-HCM patients. Follow-up time was greater than 10 years in more than half of all patients. Mortality was below 7% and not different between groups. Children with N-HCM presented at a younger age and there was less time of survival without hospitalization for heart failure or intervention in N-HCM compared to S-HCM patients. Clinical functional status improved over time in N-HCM patients. On long-term follow-up, left ventricular posterior wall thickness indexed to body surface area decreased in N-HCM and increased in S-HCM patients. There was a trend to lower risk for severe arrhythmic events in N-HCM patients and only S-HCM individuals received an implantable cardioverter-defibrillator. There were no differences between groups in ventricular function, ECG and CPET parameters. Myocardial fibrosis as assessed by histopathology of myocardial specimens and cardiovascular magnetic resonance with late gadolinium enhancement or T1 mapping was present in both groups.
CONCLUSIONS
CONCLUSIONS
When compared to S-HCM patients, children with N-HCM have increased morbidity during early disease course, but favorable long-term outcome with low mortality, stagnation of myocardial hypertrophy, and low risk for malignant arrhythmias.
Identifiants
pubmed: 31737538
doi: 10.21037/cdt.2019.05.01
pii: cdt-09-S2-S299
pmc: PMC6837940
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S299-S309Informations de copyright
2019 Cardiovascular Diagnosis and Therapy. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Rev Endocr Metab Disord. 2006 Dec;7(4):251-5
pubmed: 17177115
Circulation. 1998 Dec 8;98(23):2505-8
pubmed: 9843454
J Am Coll Cardiol. 2003 Sep 3;42(5):873-9
pubmed: 12957435
J Clin Invest. 2011 Mar;121(3):1026-43
pubmed: 21339643
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R220-6
pubmed: 16987887
Heart. 2013 Apr;99(8):534-41
pubmed: 23339826
Lancet. 2001 Feb 10;357(9254):420-4
pubmed: 11273061
Circ Res. 2017 Sep 15;121(7):749-770
pubmed: 28912181
Am J Med Genet A. 2012 Jun;158A(6):1414-21
pubmed: 22585553
BMJ Open. 2012 Oct 11;2(5):null
pubmed: 23065447
J Clin Invest. 2000 Dec;106(11):1351-9
pubmed: 11104788
Nat Genet. 2007 Aug;39(8):1007-12
pubmed: 17603483
Lancet. 1997 Jul 12;350(9071):127-33
pubmed: 9228976
J Am Coll Cardiol. 2000 Dec;36(7):2212-8
pubmed: 11127463
N Engl J Med. 2000 Jun 15;342(24):1778-85
pubmed: 10853000
J Am Soc Echocardiogr. 2003 Jul;16(7):777-802
pubmed: 12835667
J Cardiovasc Magn Reson. 2012 Dec 28;14:88
pubmed: 23272651
Am J Med Genet A. 2015 Apr;167A(4):744-51
pubmed: 25708222
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):538-544
pubmed: 29088344
Int J Cardiol. 2017 Oct 15;245:92-98
pubmed: 28768581
Circulation. 2018 Jul 3;138(1):29-36
pubmed: 29490994
Cardiovasc Res. 2015 Apr 1;105(4):409-23
pubmed: 25631583
J Cardiovasc Magn Reson. 2012 Sep 10;14:63
pubmed: 22963517
Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H231-43
pubmed: 22058153
J Am Coll Cardiol. 2011 Dec 13;58(25):2703-38
pubmed: 22075468
Rev Neurol. 2017 May 17;64(s03):S13-S17
pubmed: 28524213
Heart Rhythm. 2011 Aug;8(8):1308-39
pubmed: 21787999
J Am Soc Echocardiogr. 2010 Jun;23(6):581-90
pubmed: 20362415
Congenit Heart Dis. 2014 Mar-Apr;9(2):144-50
pubmed: 23750712
Annu Rev Genomics Hum Genet. 2005;6:45-68
pubmed: 16124853
Am J Med Sci. 2016 Jan;351(1):101-10
pubmed: 26802765
Cell. 2001 Feb 23;104(4):557-67
pubmed: 11239412
J Am Soc Echocardiogr. 1988 Jan-Feb;1(1):31-47
pubmed: 2978807
Eur Heart J. 2010 Nov;31(22):2715-26
pubmed: 20823110
Nat Genet. 2001 Dec;29(4):465-8
pubmed: 11704759
Europace. 2012 May;14(5):724-33
pubmed: 22094454
J Clin Invest. 2010 Oct;120(10):3520-9
pubmed: 20811150
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Surg. 1961 Aug;154:181-9
pubmed: 13772904
Am J Hum Genet. 2002 Jun;70(6):1555-63
pubmed: 11992261
Am J Hum Genet. 2016 Jul 7;99(1):247
pubmed: 27392081
Am J Cardiol. 2015 Oct 1;116(7):1116-21
pubmed: 26272816
Int J Cardiol. 2013 Jun 20;166(2):494-8
pubmed: 22204848
Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77
pubmed: 12524257
J Am Soc Echocardiogr. 2002 Jan;15(1):20-8
pubmed: 11781550
Am J Hum Genet. 2013 Jul 11;93(1):173-80
pubmed: 23791108
Br Heart J. 1992 Dec;68(6):586-8
pubmed: 1467053
Am Heart J. 2012 Sep;164(3):442-8
pubmed: 22980313
Circulation. 2008 Oct 7;118(15):1541-9
pubmed: 18809796
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Eur Heart J. 2008 May;29(9):1160-7
pubmed: 18385119
J Am Coll Cardiol. 1995 Dec;26(7):1699-708
pubmed: 7594106
Eur Heart J. 2014 Aug 7;35(30):2010-20
pubmed: 24126876
Eur Heart J. 2001 Apr;22(8):702-11
pubmed: 11286528
Int J Cardiovasc Imaging. 2006 Jun-Aug;22(3-4):493-5
pubmed: 16267621
Arch Dis Child. 2007 Feb;92(2):128-32
pubmed: 16990350
J Clin Invest. 2011 Mar;121(3):844-7
pubmed: 21339640
Magn Reson Med. 2002 Feb;47(2):372-83
pubmed: 11810682
N Engl J Med. 2004 Mar 25;350(13):1320-7
pubmed: 15044643
Heart. 1997 Mar;77(3):229-33
pubmed: 9093039
Eur Heart J. 2003 Nov;24(21):1965-91
pubmed: 14585256
Heart Fail Clin. 2018 Apr;14(2):225-235
pubmed: 29525650
Magn Reson Med. 2004 Jul;52(1):141-6
pubmed: 15236377
N Engl J Med. 2003 Jan 23;348(4):295-303
pubmed: 12540642
Am J Med. 2016 Nov;129(11):1170-1177
pubmed: 27039955
Arch Dis Child. 2014 Jul;99(7):629-34
pubmed: 24534818
Am J Cardiol. 1997 Sep 1;80(5):595-600
pubmed: 9294988
Pediatrics. 2010 Oct;126(4):746-59
pubmed: 20876176
PLoS One. 2015 May 12;10(5):e0126707
pubmed: 25966025
PLoS One. 2017 Jun 5;12(6):e0178905
pubmed: 28582432
Circulation. 2005 Aug 30;112(9):1332-8
pubmed: 16116056